Cover Image: January 2008 Scientific American Magazine See Inside

Regaining Lost Luster

New developments and clinical trials breathe life back into gene therapy















Share on Tumblr

Even if gene therapy conquers these challenges, will it ever overcome its negative reputation? Some scientists maintain that it has never been that unsafe, relatively speaking. “If you compare the safety profile of gene drugs in development versus the traditional small-molecule pharmaceutical drugs, there’s no evidence that gene therapy is any more dangerous,” says Savio Woo, an oncologist at Mount Sinai Hospital in New York City. Thousands of patients have been treated, and only a few adverse events have been reported, he states; the leukemia that developed in three “bubble boy” patients may have been a side effect specific to the therapeutic gene, which stimulates immune cell growth. “Any time a few cells divide a lot, you always worry about secondary genetic changes, which is how cancers form,” notes Mark Kay, a geneticist at Stanford University.

As the field continues to evolve and improve, scientists hope that the public’s perceptions of it will, too.

 “We clearly have had clinical successes, and now we’re on the threshold of achieving many more,” says ASGT president Nienhuis. “I think we’re going to hear a lot about them in the next several years.”



This article was originally published with the title Regaining Lost Luster.



Subscribe     Buy This Issue

Already a Digital subscriber? Sign-in Now
If your institution has site license access, enter here.

ABOUT THE AUTHOR(S)

Melinda Wenner is a freelance writer based in New York City.


3 Comments

Add Comment
View
  1. 1. kontiki 08:13 AM 12/31/07

    virus ,we can not control them now.You speak of pay loads? A freudian slip,by the way hows your funding comeing along this round?

    Reply | Report Abuse | Link to this
  2. 2. AAkutagawa 06:25 PM 4/25/10

    I didn't think about the suppression of auto-immune responses in conjunction with gene therapy. It seems to be a challenging issue in it of itself.

    Andrea Akutagawa
    http://liberate.it/

    Reply | Report Abuse | Link to this
  3. 3. damatriarch06 08:29 AM 8/14/10

    Engineering a virus with the ability to 'sneak' past the body's immune responses is inherently dangerous. How can this risk be controlled?

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Science Jobs of the Week

Email this Article

Regaining Lost Luster: Scientific American Magazine

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X